{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:14:33Z","timestamp":1791400473108,"version":"4.3.3"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"Supplement_C","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Since the first description of Brugada syndrome (BrS), several studies were carried out aimed at diagnosis, arrhythmic risk stratification, and available strategies for sudden death prevention. In high-risk patients, the use of an implantable cardiac defibrillator was an evident option since the first description of the syndrome. Nevertheless, this strategy, while proven, as expected, to be effective in sudden death prevention, does not prevent arrhythmias and may not be an adequate or accepted solution for all patients. The need of a non-pharmacological therapy as a potential solution based on the electrophysiological mechanisms underlying the syndrome, led to search for substrate as target for catheter ablation. Advances in the tools, technology, and technical approach enabled to launch studies aimed at mapping the epicardium of patients with BrS in order to identify and ablate the substrate. As described in previous work and in our experience, an anatomically identifiable electrical substrate, which correspond to the typical ECG, is the ablation target. Complete substrate is better identified in a larger area with sodium-channel-blockers. Ablation of all abnormal electrical potentials is able to normalize the ECG and prevent arrhythmias induction. Encouraging preliminary data, if confirmed by longer follow-up and by multicentre randomized study, could change the whole therapeutic management in BrS patients.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suad005","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:55:09Z","timestamp":1682531709000},"page":"C38-C43","source":"Crossref","is-referenced-by-count":4,"title":["Transcatheter ablation in patients with Brugada syndrome"],"prefix":"10.1093","volume":"25","author":[{"given":"Stefano","family":"Grossi","sequence":"first","affiliation":[{"name":"Department of Cardiology, AO Ordine Mauriziano , Largo Turati 62, Turin 10128 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AO Ordine Mauriziano , Largo Turati 62, Turin 10128 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pintor","sequence":"additional","affiliation":[{"name":"Johnson & Johnson MedTech, Biosense Webster , Via del mare 56, 00071 Pomezia (Rome) , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AO Ordine Mauriziano , Largo Turati 62, Turin 10128 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenzo","family":"Gaita","sequence":"additional","affiliation":[{"name":"University of Turin , Via Verdi 8, Turin 10124 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"2023042617393135400_suad005-B1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report","volume":"20","author":"Brugada","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2023042617393135400_suad005-B2","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC) endorsed by: association for European paediatric and congenital cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2023042617393135400_suad005-B3","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC) endorsed by the association for European paediatric and congenital cardiology (AEPC)","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2023042617393135400_suad005-B4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.amjcard.2014.10.007","article-title":"Prevalence of type 1 Brugada electrocardiographic pattern evaluated by twelve-lead twenty-four-hour holter monitoring","volume":"115","author":"Cerrato","year":"2015","journal-title":"Am J Cardiol"},{"key":"2023042617393135400_suad005-B5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2017.03.019","article-title":"Etiological diagnosis, prognostic significance and role of electrophysiological study in patients with Brugada ECG and syncope","volume":"241","author":"Giustetto","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023042617393135400_suad005-B6","first-page":"141","article-title":"Meta-analysis of clinical outcome after implantable cardioverter-defibrillator implantation in patients with Brugada syndrome","volume":"5","author":"Dereci","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023042617393135400_suad005-B7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/eurheartj\/ehaa839","article-title":"On risk stratification and its paradoxes","volume":"42","author":"Brugada","year":"2021","journal-title":"Eur Heart J"},{"key":"2023042617393135400_suad005-B8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"2023042617393135400_suad005-B9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2023042617393135400_suad005-B10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023042617393135400_suad005-B11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/CIRCEP.115.003576","article-title":"Quinidine in Brugada syndrome: still a long way to go\u2026","volume":"8","author":"Probst","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023042617393135400_suad005-B12","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.hrthm.2021.08.005","article-title":"Radiofrequency ablation in Brugada syndrome","volume":"18","author":"Nademanee","year":"2021","journal-title":"Heart Rhythm"},{"key":"2023042617393135400_suad005-B13","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"2023042617393135400_suad005-B14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","article-title":"Brugada syndrome phenotype elimination by epicardial substrate ablation","volume":"8","author":"Brugada","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023042617393135400_suad005-B15","doi-asserted-by":"crossref","first-page":"e005053","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023042617393135400_suad005-B16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.hrthm.2018.03.019","article-title":"Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review","volume":"15","author":"Fernandes","year":"2018","journal-title":"Heart Rhythm"},{"key":"2023042617393135400_suad005-B17","first-page":"724","article-title":"Shanghai Score system for diagnosis of Brugada syndrome: validation of the score system and system and reclassification of the patients","volume":"4","author":"Kawada","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023042617393135400_suad005-B18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/europace\/euz132","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias","volume":"21","author":"Cronin","year":"2019","journal-title":"Europace"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/25\/Supplement_C\/C38\/50100221\/suad005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/25\/Supplement_C\/C38\/50100221\/suad005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:55:23Z","timestamp":1682531723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/25\/Supplement_C\/C38\/7143278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":18,"journal-issue":{"issue":"Supplement_C","published-online":{"date-parts":[[2023,4,26]]},"published-print":{"date-parts":[[2023,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suad005","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2023,4,26]]}}}